Study Shows Improved Outcomes for Pulmonary Embolism with Catheter-Directed Thrombolysis

The PRAGUE-26 study, published in the New England Journal of Medicine, found that catheter-directed thrombolysis with alteplase combined with anticoagulation significantly reduced adverse events for patients with intermediate-high-risk acute pulmonary embolism. Compared to anticoagulation alone, this treatment lowered the risk of death, recurrent pulmonary embolism, or cardiorespiratory decompensation within seven days. This research offers a potentially more effective treatment strategy for a serious medical condition.